Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells
Chang‐Ching Lin(University of Michigan–Ann Arbor), Duxin Sun(University of Michigan)
Cited by 27
Related Papers
Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options
|Scientific Reports|2015|62
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
|Nature Chemical Biology|2023|62
A gastrointestinal locally activating Janus kinase inhibitor to treat ulcerative colitis
|Journal of Biological Chemistry|2023|7
Identification of LRP8, CDCA7, and MLK4 as Novel Therapeutic Targets for Cancer Stem Cells in Triple-Negative Breast Cancer
|Deep Blue (University of Michigan)|2018|0
Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0